Stroke Risk Assessment in Atrial Fibrillation

The question asks for the appropriate scoring system to evaluate the risk of stroke in patients diagnosed with non-valvular chronic atrial fibrillation (AF) who are currently on oral anticoagulation.

Understanding the CHA₂DS₂-VASc Score

The $CHA_2DS_2-VASc$ score is specifically designed to predict the risk of stroke in patients with atrial fibrillation. It considers various clinical factors contributing to thromboembolism.

• Congestive heart failure (1 point)
• Hypertension (1 point)
• A₂ge ≥ 75 years (2 points)
• Diabetes mellitus (1 point)
• S₂troke/Transient Ischemic Attack/Systemic Embolism (2 points)
• Vascular disease (previous MI, peripheral artery disease, or aortic plaque) (1 point)
• Age 65-74 years (1 point)
• Scex (female gender) (1 point)

A higher score indicates a greater risk of stroke, guiding the decision for anticoagulation therapy.

Evaluating Other Scoring Systems

The other options are used for different clinical assessments:

• HAS-BLED Score: Used to assess the risk of major bleeding in patients with atrial fibrillation who are receiving anticoagulation. It is not used for stroke risk assessment.
• AMT-4 Score: This score is typically related to assessing the risk of falls in the elderly and is not relevant for stroke risk in AFib.
• CURB-65 Score: Utilized to assess the severity of community-acquired pneumonia and guide decisions about inpatient versus outpatient treatment.

Therefore, the $CHA_2DS_2-VASc$ score is the standard and appropriate system for assessing stroke risk in this patient group.